The DREAM-PRIDE research is a prospective, multicenter, randomized, parallel-controlled clinical trial. It aims to evaluate whether drug-eluting stent treatment for symptomatic intracranial atherosclerotic stenosis is more effective in reducing major endpoint events compared to medical treatment.